These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
757 related items for PubMed ID: 18209509
1. Detection of specific IgE antibodies in sera of Japanese birch-allergic patients using recombinant allergens Bet v 1, Bet v 2 and Bet v 4. Shirasaki H, Yamamoto T, Koyanagi Y, Watanabe N, Himi T. Allergol Int; 2008 Mar; 57(1):93-6. PubMed ID: 18209509 [Abstract] [Full Text] [Related]
2. Different IgE reactivity profiles in birch pollen-sensitive patients from six European populations revealed by recombinant allergens: an imprint of local sensitization. Movérare R, Westritschnig K, Svensson M, Hayek B, Bende M, Pauli G, Sorva R, Haahtela T, Valenta R, Elfman L. Int Arch Allergy Immunol; 2002 Aug; 128(4):325-35. PubMed ID: 12218371 [Abstract] [Full Text] [Related]
3. Detection of specific IgE antibodies in the sera of patients allergic to birch pollen using recombinant allergens Bet v 1, Bet v 2, Bet v 4: evaluation of different IgE reactivity profiles. Rossi RE, Monasterolo G, Monasterolo S. Allergy; 2003 Sep; 58(9):929-32. PubMed ID: 12911423 [Abstract] [Full Text] [Related]
4. The Clinical Impact of Bet v 6 in Birch Pollen-Sensitized Patients. Gellrich D, Eder K, San Nicoló M, Berghaus A, Gröger M. Int Arch Allergy Immunol; 2017 Sep; 173(1):34-43. PubMed ID: 28494455 [Abstract] [Full Text] [Related]
5. Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen. Subbarayal B, Schiller D, Möbs C, de Jong NW, Ebner C, Reider N, Bartel D, Lidholm J, Pfützner W, Gerth van Wijk R, Vieths S, Bohle B. Allergy; 2013 Nov; 68(11):1377-86. PubMed ID: 24053565 [Abstract] [Full Text] [Related]
6. High correlation of specific IgE sensitization between birch pollen, soy and apple allergens indicates pollen-food allergy syndrome among birch pollen allergic patients in northern China. Hao GD, Zheng YW, Wang ZX, Kong XA, Song ZJ, Lai XX, Spangfort MD. J Zhejiang Univ Sci B; 2016 May; 17(5):399-404. PubMed ID: 27143268 [Abstract] [Full Text] [Related]
7. Clinical benefit of component-resolved diagnosis in Japanese birch-allergic patients with a convincing history of apple or peach allergy. Shirasaki H, Yamamoto T, Abe S, Kanaizumi E, Kikuchi M, Himi T. Auris Nasus Larynx; 2017 Aug; 44(4):442-446. PubMed ID: 27816237 [Abstract] [Full Text] [Related]
8. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis. Rossi RE, Monasterolo G, Coco G, Operti D. Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987 [Abstract] [Full Text] [Related]
9. Recombinant allergen profiles and health-related quality of life in seasonal allergic rhinitis. Canis M, Gröger M, Becker S, Klemens C, Kramer MF. Allergy Asthma Proc; 2010 Oct; 31(3):219-26. PubMed ID: 20615322 [Abstract] [Full Text] [Related]
10. Recombinant marker allergens in diagnosis of patients with allergic rhinoconjunctivitis to tree and grass pollens. Canis M, Gröger M, Becker S, Klemens C, Kramer MF. Am J Rhinol Allergy; 2011 Oct; 25(1):36-9. PubMed ID: 21711974 [Abstract] [Full Text] [Related]
11. Characterization of a hypoallergenic recombinant Bet v 1 variant as a candidate for allergen-specific immunotherapy. Kahlert H, Suck R, Weber B, Nandy A, Wald M, Keller W, Cromwell O, Fiebig H. Int Arch Allergy Immunol; 2008 Oct; 145(3):193-206. PubMed ID: 17912007 [Abstract] [Full Text] [Related]
12. Soybean allergy in patients allergic to birch pollen: clinical investigation and molecular characterization of allergens. Mittag D, Vieths S, Vogel L, Becker WM, Rihs HP, Helbling A, Wüthrich B, Ballmer-Weber BK. J Allergy Clin Immunol; 2004 Jan; 113(1):148-54. PubMed ID: 14713921 [Abstract] [Full Text] [Related]
13. Oral exposure to Mal d 1 affects the immune response in patients with birch pollen allergy. Geroldinger-Simic M, Kinaciyan T, Nagl B, Baumgartner-Durchschlag U, Huber H, Ebner C, Lidholm J, Bartel D, Vieths S, Jahn-Schmid B, Bohle B. J Allergy Clin Immunol; 2013 Jan; 131(1):94-102. PubMed ID: 22921871 [Abstract] [Full Text] [Related]
14. Chimeras of Bet v 1 and Api g 1 reveal heterogeneous IgE responses in patients with birch pollen allergy. Gepp B, Lengger N, Bublin M, Hemmer W, Breiteneder H, Radauer C. J Allergy Clin Immunol; 2014 Jul; 134(1):188-94. PubMed ID: 24529686 [Abstract] [Full Text] [Related]
15. Development of new IgE specificities to allergenic components in birch pollen extract during specific immunotherapy studied with immunoblotting and Pharmacia CAP System. Movérare R, Elfman L, Vesterinen E, Metso T, Haahtela T. Allergy; 2002 May; 57(5):423-30. PubMed ID: 11972482 [Abstract] [Full Text] [Related]
16. Evaluation of recombinant allergens Bet v 1 and Bet v 2 (profilin) by Pharmacia CAP system in patients with pollen-related allergy to birch and apple. Rossi RE, Monasterolo G, Operti D, Corsi M. Allergy; 1996 Dec; 51(12):940-5. PubMed ID: 9020425 [Abstract] [Full Text] [Related]
17. Immunoblotting in the diagnosis of cross-reactivity in children allergic to birch. Cudowska B, Kaczmarski M, Restani P. Rocz Akad Med Bialymst; 2005 Dec; 50():268-73. PubMed ID: 16358981 [Abstract] [Full Text] [Related]
18. Correlations between alder specific IgE and alder-related tree pollen specific IgE by RAST method. Maeda Y, Ono E, Fukutomi Y, Taniguchi M, Akiyama K. Allergol Int; 2008 Mar; 57(1):79-81. PubMed ID: 18089941 [Abstract] [Full Text] [Related]
19. Recombinant birch pollen allergens (rBet v 1 and rBet v 2) contain most of the IgE epitopes present in birch, alder, hornbeam, hazel, and oak pollen: a quantitative IgE inhibition study with sera from different populations. Niederberger V, Pauli G, Grönlund H, Fröschl R, Rumpold H, Kraft D, Valenta R, Spitzauer S. J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):579-91. PubMed ID: 9802365 [Abstract] [Full Text] [Related]
20. Vig r 6, the cytokinin-specific binding protein from mung bean (Vigna radiata) sprouts, cross-reacts with Bet v 1-related allergens and binds IgE from birch pollen allergic patients' sera. Guhsl EE, Hofstetter G, Hemmer W, Ebner C, Vieths S, Vogel L, Breiteneder H, Radauer C. Mol Nutr Food Res; 2014 Mar; 58(3):625-34. PubMed ID: 23996905 [Abstract] [Full Text] [Related] Page: [Next] [New Search]